BioMarin Pharmaceuticals
BMRN
BMRN
535 hedge funds and large institutions have $16.1B invested in BioMarin Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 195 increasing their positions, 171 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 495 → 535 (+40)
1.65% more ownership
Funds ownership: 98.94% → 100.58% (+1.6%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
535
Holding in Top 10
7
Calls
$319M
Puts
$247M
Top Buyers
| 1 | +$182M | |
| 2 | +$119M | |
| 3 | +$117M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$87.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$70.8M |
Top Sellers
| 1 | -$64.7M | |
| 2 | -$54.7M | |
| 3 | -$51.6M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$51.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$49.3M |